Other factors shown to be involved in the improvement in anaemia following SGLT‐2 inhibition include reduced hepcidin and ferritin leading to increased iron absorption and mobilization and increased hypoxia‐inducible factor 2α.28 The gene discussed is HAMP; the disease is anemia (phenotype).